Bifidobacterium infantis BI02 and No Human Health Outcome Reported

• Evaluating the Quality of Selected Commercial Probiotic Products, Both Dietary Supplements and Foods for Special Medical Purposes.

  • 2026-01-20
  • Foods (Basel, Switzerland) 15(2)
  • • Anna Zawistowska-Rojek
    • Justyna Rybak
    • Paulina Smoleń
    • Agnieszka Kociszewska
    • Paweł Rudnicki-Velasquez
    • Karolina Węgrzyńska
    • Tomasz Zaręba
    • Stefan Tyski
    • Anna Baraniak

  • PubMed: 41596971
  • DOI: 10.3390/foods15020373

  1 Insight on

  • No Human Health Outcome Reported

  • Low evidence

  The abstract evaluates the quality, microbial composition, and safety of commercial probiotic products and does not report any health outcomes from consuming Bifidobacterium infantis BI02.

  Effect

  Neutral

  Effect size

  Small